The correlation between FAM225A levels and patient clinicopathological characteristics suggested that higher FAM225A expression tended to correlate with more profound lymphatic metastasis rate, larger tumor size, and more advanced tumor stages (Table S1). The gene discussed is FAM225A; the disease is neoplasm.